Citadel Advisors
PZRX

Citadel Advisors’s PhaseRx, Inc. PZRX Stock Holding History

Citadel Advisors’s Portfolio PZRX Stock Details PZRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,512
Closed -$16K – 8773
2017
Q3 		$16K Buy
19,512
+9,046
+86% +$6.75K ﹤0.01% 7403
2017
Q2 		$10K Buy
+10,466
New +$12.3K ﹤0.01% 7375

Other funds holding PZRX

RFC
Regions Financial Corp Birmingham, Alabama $15.4B AUM 21.7% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citadel Advisors's PZRX Position: Q4 2017 in Review

Citadel Advisors sold out of PhaseRx, Inc. (PZRX) in Q4 2017, closing a stake of 19,512 shares — an estimated $16K sold.

Citadel Advisors first reported a position in PZRX in Q2 2017 and held it in 2 quarters. The position peaked at $16K in Q3 2017. 6 funds tracked by Wall St. Rank hold PZRX as of Q4 2017.

  • Citadel Advisors reported no remaining PhaseRx, Inc. position as of Q4 2017 after selling out during the quarter.
  • Citadel Advisors sold 19,512 PhaseRx, Inc. shares in Q4 2017, an estimated $16K.
  • Citadel Advisors first reported a position in PhaseRx, Inc. in Q2 2017 and held it in 2 quarters.
  • Citadel Advisors's PhaseRx, Inc. position peaked at $16K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held PhaseRx, Inc. as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.